Tags: Cancer | hpv | vaccine | fda | gardisil

Stronger HPV Vaccine

Wednesday, 10 Dec 2014 04:07 PM

The drugmaker Merck & Co. Inc. has received approval for an updated version of its Gardasil vaccine that protects against an additional five strains of the virus that causes most cases of cervical cancer.
 
The Food and Drug Administration approved the company's Gardasil 9, which protects against nine strains of the virus called HPV, or human papillomavirus. That's up from four strains covered by its original vaccine approved in 2006.

The FDA says the updated Gardasil has the potential to prevent roughly 90 percent of cervical, vulvar, vaginal and anal cancers. It also guards against some types of genital warts.

Original Gardasil protected against strains blamed for 70 percent of U.S. cervical cancers.

About 75 to 80 percent of men and women are infected with HPV during their lifetime. Most don't show symptoms.

© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

 
1Like our page
2Share
FDA-Approved-Drugs
The drugmaker Merck Co. Inc. has received approval for an updated version of its Gardasil vaccine that protects against an additional five strains of the virus that causes most cases of cervical cancer. The Food and Drug Administration approved the company's Gardasil 9,...
hpv, vaccine, fda, gardisil
133
2014-07-10
Wednesday, 10 Dec 2014 04:07 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved